Abstract
Valproic acid (VPA) is an anticonvulsant drug with demonstrated efficacy in the treatment of mania. In the present study, we found that chronic exposure of rat C6 glioma cells to VPA induces a coordinate decrease in multiple components of the β-adrenergic receptor- (β-AR) coupled cyclic adenosine 3′-5′monophosphate (cAMP) generating system. Chronic VPA decreased the number of β-ARs in a time- and concentration-dependent manner; the decrease of β-ARs was largely β1-AR selective and affected β-ARs in both the high- and low-affinity states. Chronic VPA also significantly attenuated receptor- and postreceptor-stimulated cAMP production, [3H]forskolin binding sites, immunolabeling of Gαs 45, and cholera toxin catalyzed ADP-ribosylation of Gαs 52 and 45. Although the precise underlying mechanisms remain to be elucidated, such profound long-term changes in the functioning of this key signaling pathway may help explain the antimanic effects of chronic VPA treatment and are worthy of further study.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chen, G., Manji, H., Wright, C. et al. Effects of Valproic Acid on β-adrenergic Receptors, G-proteins, and Adenylyl Cyclase in Rat C6 Glioma Cells. Neuropsychopharmacol 15, 271–280 (1996). https://doi.org/10.1016/0893-133X(95)00207-T
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1016/0893-133X(95)00207-T
Keywords
This article is cited by
-
Transcriptional analysis of sodium valproate in a serotonergic cell line reveals gene regulation through both HDAC inhibition-dependent and independent mechanisms
The Pharmacogenomics Journal (2021)
-
Aspects of cAMP Signaling in Epileptogenesis and Seizures and Its Potential as Drug Target
Neurochemical Research (2020)
-
Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers
Molecular Psychiatry (2004)